TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 93 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2018. The put-call ratio across all filers is 5.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $43,000 | -66.9% | 32,074 | -72.1% | 0.02% | -67.3% |
| Q4 2018 | $130,000 | -46.3% | 114,874 | +31.0% | 0.06% | -71.2% |
| Q3 2018 | $242,000 | +278.1% | 87,704 | +392.6% | 0.19% | +961.1% |
| Q2 2018 | $64,000 | -82.0% | 17,804 | -84.6% | 0.02% | -64.0% |
| Q1 2018 | $356,000 | – | 115,834 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 330,000 | $2,353,000 | 0.98% |
| EcoR1 Capital, LLC | 633,400 | $4,516,000 | 0.80% |
| DLD Asset Management, LP | 570,000 | $4,059,000 | 0.53% |
| Rhenman & Partners Asset Management AB | 300,000 | $2,139,000 | 0.31% |
| Eventide Asset Management | 600,000 | $4,278,000 | 0.27% |
| Tekla Capital Management LLC | 1,004,322 | $7,161,000 | 0.26% |
| Rock Springs Capital Management LP | 698,000 | $4,977,000 | 0.25% |
| DLD Asset Management, LP | 230,000 | $1,640,000 | 0.21% |
| Worth Venture Partners, LLC | 29,325 | $209,000 | 0.18% |
| Crestline Management, LP | 161,403 | $1,151,000 | 0.15% |